Risk of Fracture Among Older Adults With Primary Hyperparathyroidism Receiving Parathyroidectomy vs Nonoperative Management
- PMID: 34842909
- PMCID: PMC8630642
- DOI: 10.1001/jamainternmed.2021.6437
Risk of Fracture Among Older Adults With Primary Hyperparathyroidism Receiving Parathyroidectomy vs Nonoperative Management
Abstract
Importance: Primary hyperparathyroidism (PHPT) contributes to the development and progression of osteoporosis in older adults. The effectiveness of parathyroidectomy for reducing fracture risk in older adults is unknown.
Objective: To compare the incidence of clinical fracture among older adults with PHPT treated with parathyroidectomy vs nonoperative management.
Design, setting, and participants: This was a population-based, longitudinal cohort study of all Medicare beneficiaries with PHPT from 2006 to 2017. Multivariable, inverse probability weighted Cox proportional hazards and Fine-Gray competing risk regression models were constructed to determine the association of parathyroidectomy vs nonoperative management with incident fracture. Data analysis was conducted from February 17, 2021, to September 14, 2021.
Main outcomes and measures: The primary outcome was clinical fracture at any anatomic site not associated with major trauma during the follow-up period.
Results: Among the 210 206 Medicare beneficiaries with PHPT (mean [SD] age, 75 [6.8] years; 165 637 [78.8%] women; 183 433 [87.3%] White individuals), 63 136 (30.0%) underwent parathyroidectomy within 1 year of diagnosis, and 147 070 (70.0%) were managed nonoperatively. During a mean (SD) follow-up period of 58.5 (35.5) months, the unadjusted incidence of fracture was 10.2% in patients treated with parathyroidectomy. During a mean (SD) follow-up of 52.5 (33.8) months, the unadjusted incidence of fracture was 13.7% in patients observed nonoperatively. On multivariable analysis, parathyroidectomy was associated with lower adjusted rates of any fracture (hazard ratio [HR], 0.78; 95% CI, 0.76-0.80]) and hip fracture (HR, 0.76; 95% CI, 0.72-0.79). At 2, 5, and 10 years, parathyroidectomy was associated with adjusted absolute fracture risk reduction of 1.2% (95% CI, 1.0-1.4), 2.8% (95% CI, 2.5-3.1), and 5.1% (95% CI, 4.6-5.5), respectively, compared with nonoperative management. On subgroup analysis, there were no significant differences in the association of parathyroidectomy with fracture risk by age group, sex, frailty, history of osteoporosis, or meeting operative guidelines. Fine-Gray competing risk regression confirmed parathyroidectomy was associated with a lower probability of any fracture and hip fracture when accounting for the competing risk of death (HR, 0.84; 95% CI, 0.82-0.85; and HR, 0.83; 95% CI, 0.80-0.85, respectively).
Conclusions and relevance: This longitudinal cohort study found that parathyroidectomy was associated with a lower risk of any fracture and hip fracture among older adults with PHPT, suggesting a clinically meaningful benefit of operative management in this population.
Conflict of interest statement
Figures
Comment in
-
Parathyroidectomy in Elderly Individuals With Primary Hyperparathyroidism: To Operate or Not to Operate.JAMA Intern Med. 2022 Jan 1;182(1):7-8. doi: 10.1001/jamainternmed.2021.6816. JAMA Intern Med. 2022. PMID: 34842895 No abstract available.
Similar articles
-
Patient Factors Associated With Parathyroidectomy in Older Adults With Primary Hyperparathyroidism.JAMA Surg. 2021 Apr 1;156(4):334-342. doi: 10.1001/jamasurg.2020.6175. JAMA Surg. 2021. PMID: 33404646 Free PMC article.
-
Adverse Cardiovascular Outcomes Among Older Adults With Primary Hyperparathyroidism Treated With Parathyroidectomy Versus Nonoperative Management.Ann Surg. 2023 Aug 1;278(2):e302-e308. doi: 10.1097/SLA.0000000000005691. Epub 2022 Aug 25. Ann Surg. 2023. PMID: 36005546 Free PMC article.
-
Kidney Stone Events Following Parathyroidectomy vs Nonoperative Management for Primary Hyperparathyroidism.J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2801-e2811. doi: 10.1210/clinem/dgac193. J Clin Endocrinol Metab. 2022. PMID: 35363858 Free PMC article.
-
The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review.World J Surg. 2011 Sep;35(9):1993-2005. doi: 10.1007/s00268-011-1068-9. World J Surg. 2011. PMID: 21713580 Review.
-
Long-Term Skeletal Outcomes of Primary Hyperparathyroidism Patients After Treatment with Parathyroidectomy: A Systematic Review and Meta-Analysis.Horm Metab Res. 2018 Mar;50(3):242-249. doi: 10.1055/s-0043-125334. Epub 2018 Jan 30. Horm Metab Res. 2018. PMID: 29381879 Review.
Cited by
-
Skeletal phenotypes in postmenopausal women affected by primary hyperparathyroidism.Front Endocrinol (Lausanne). 2024 Oct 29;15:1475147. doi: 10.3389/fendo.2024.1475147. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39539933 Free PMC article.
-
Parathyroidectomy and the Development of New Depression Among Adults With Primary Hyperparathyroidism.JAMA Surg. 2024 Sep 4:e243509. doi: 10.1001/jamasurg.2024.3509. Online ahead of print. JAMA Surg. 2024. PMID: 39230896
-
Patient Characteristics, Management, and Outcomes in a Novel Cohort of Primary Hyperparathyroidism.J Endocr Soc. 2024 May 9;8(8):bvae096. doi: 10.1210/jendso/bvae096. eCollection 2024 Jul 1. J Endocr Soc. 2024. PMID: 38988672 Free PMC article.
-
Interhospital variation in the nonoperative management of acute cholecystitis.PLoS One. 2024 Jun 10;19(6):e0300851. doi: 10.1371/journal.pone.0300851. eCollection 2024. PLoS One. 2024. PMID: 38857278 Free PMC article.
-
Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism.Endocr Metab Immune Disord Drug Targets. 2024;24(8):991-1006. doi: 10.2174/0118715303260423231122111705. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38644730 Free PMC article.
References
-
- Coker LH, Rorie K, Cantley L, et al. . Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg. 2005;242(5):642-650. doi:10.1097/01.sla.0000186337.83407.ec - DOI - PMC - PubMed
